| 1 |
Agarwal A, Basmaji J, Muttalib F, Granton D, Chaudhuri D, Chetan D, et al. High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anesth Can Anesth. 2020; 67(9):1217-48.
|
| 2 |
Jiang WQ, Li XS, Zhong WH, Huang LQ, Lin XJ, Wen MY, et al. Comparison of clinical characteristics in patients with coronavirus disease and influenza A in Guangzhou, China. World J Emerg Med. 2021; 12(4):287-92.
doi: 10.5847/wjem.j.1920-8642.2021.04.006
pmid: 34512825
|
| 3 |
Morin F, Dubie E, Serruys A, Usseglio P, Richard JC, Douillet D, et al. Interhospital transport of patients with COVID-19 under high-flow nasal cannula (HFNC). Am J Emerg Med. 2021; 50:791-2.
doi: 10.1016/j.ajem.2021.03.002
|
| 4 |
Mellado-Artigas R, Mujica LE, Ruiz ML, Ferreyro BL, Angriman F, Arruti E, et al. Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study. J Intensive Care. 2021; 9(1):23.
doi: 10.1186/s40560-021-00538-8
pmid: 33673863
|
| 5 |
Li J, Fink JB, Ehrmann S. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur Respir J. 2020; 55(5):2000892.
doi: 10.1183/13993003.00892-2020
|
| 6 |
Leonard S, Atwood CW Jr, Walsh BK, DeBellis RJ, Dungan GC, Strasser W, et al. Preliminary findings on control of dispersion of aerosols and droplets during high-velocity nasal insufflation therapy using a simple surgical mask: implications for the high-flow nasal cannula. Chest. 2020; 158(3):1046-9.
doi: S0012-3692(20)30579-1
pmid: 32247712
|
| 7 |
Carteaux G, Pons M, Morin F, Tuffet S, Lesimple A, Badat B, et al. Continuous positive airway pressure for respiratory support during COVID-19 pandemic: a frugal approach from bench to bedside. Ann Intensive Care. 2021; 11(1):38.
doi: 10.1186/s13613-021-00828-2
|
), Sylvain Leclere, Martin Petitprez, Gilles Vincent, Christine Ammirati
